Donna R. Zwas

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

Iacopo Olivotto, Artur Oręziak, Roberto Barriales‐Villa et al. · The Lancet · 2020 · 1.1K citations · Full text

Cardiomyopathy, Structural Heart Disease, Cardiovascular Disease +2

Heart regeneration in adult MRL mice

John Leferovich, Khamilia Bedelbaeva, Stefan Samulewicz et al. · Proceedings of the National Academy of Sciences · 2001 · 246 citations · Full text

Cardiac Muscle, Mrl Mice, Severe Transmural +21

Vitamin D Deficiency is a Predictor of Reduced Survival in Patients with Heart Failure; Vitamin D Supplementation Improves Outcome

Israel Gotsman, Ayelet Shauer, Donna R. Zwas et al. · European Journal of Heart Failure · 2012 · 193 citations · Full text

Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy

Sheila M. Hegde, Steven J. Lester, Scott D. Solomon et al. · Journal of the American College of Cardiology · 2021 · 175 citations · Full text

Cardiomyopathy, Echocardiographic Features, Cardiovascular Disease +8

Left Ventricular Mass and Geometry and the Risk of Ischemic Stroke

Marco R. Di Tullio, Donna R. Zwas, Ralph L. Sacco et al. · Stroke · 2003 · 133 citations · Full text